Skip to Content

Albuminuria Down in Adults With Newly Diagnosed T2DM

TUESDAY, Jan. 12, 2021 -- From 1988 to 2018, there were reductions seen in the prevalence of albuminuria and improvements in glycemic, blood pressure, and lipid control among adults with newly diagnosed type 2 diabetes, according to a study published online Jan. 8 in Diabetes Care.

Michael Fang, Ph.D., and Elizabeth Selvin, M.P.H., Ph.D., from the Johns Hopkins Bloomberg School of Public Health in Baltimore, examined the prevalence of and trends in complications among 1,486 adults with newly diagnosed diabetes (diagnosed within the past two years) from the 1988 to 1994 and 1999 to 2018 National Health and Nutrition Examination Surveys. Trends in albuminuria, reduced estimated glomerular filtration rate (eGFR), retinopathy, and self-reported cardiovascular disease were estimated.

The researchers found a significant decrease in the prevalence of albuminuria from 1988-1994 to 2011-2018 (38.9 to 18.7 percent), but there were no significant changes in the prevalence of reduced eGFR, retinopathy, or self-reported cardiovascular disease. Within the population, there were improvements in glycemic, blood pressure, and lipid control, partly explaining the decrease in albuminuria. At the time of diabetes diagnosis, complications were more common for older, lower-income, less-educated, and obese adults.

"These results suggest that there have been improvements in diabetes screening and that we are diagnosing cases earlier in the disease process," the authors write. "Nevertheless, the overall burden of complications and uncontrolled risk factors remains high."

Abstract/Full Text (subscription or payment may be required)

© 2021 HealthDay. All rights reserved.

Posted: January 2021

Read this next

More Diabetes Remission in T2DM Seen With Low-Carb Diets for Six Months

THURSDAY, Jan. 14, 2021 -- Patients with type 2 diabetes adhering to low-carbohydrate diets (LCDs) for six months may experience greater rates of diabetes remission, according to...

Euglycemic DKA ID'd in T2DM Patients With COVID-19

TUESDAY, Jan. 5, 2021 -- In a case report recently published in The American Association of Clinical Endocrinologists Clinical Case Reports, five cases of euglycemic diabetic...

Intensive Glycemic Control May Cut CV Autonomic Neuropathy Risk

MONDAY, Dec. 21, 2020 -- Cardiovascular autonomic neuropathy (CAN) risk may be reduced among type 2 diabetes patients undergoing intensive glycemic therapy, according to a study...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.